CNTY-813, lead beta islet cell therapy program as a potential functional cure for type 1 diabetes, in Investigational New Drug (IND)-enabling ...

In June 2024, Dr. An Chiying’s team achieved the first case of functional remission of type 1 diabetes using an integrative medicine strategy. This milestone marks a major clinical breakthrough for ...

Detailed price information for Lineage Cell Therapeutics Inc (LCTX-A) from The Globe and Mail including charting and trades.

The partnership draws on clinical experience from over 100 transplant patients treated with tegoprubart.

Collaboration Integrates Stem-Cell-Derived Islets with Targeted Immune ModulationZURICH, Switzerland, March 9, 2026 /PRNewswire/ -- NewcelX Ltd.

NewcelX Ltd., a clinical-stage company, has entered a strategic collaboration with Eledon Pharmaceuticals Inc., a ...

Collaboration Integrates Stem-Cell-Derived Islets with Targeted Immune Modulation ZURICH, Switzerland, March 9, 2026 /PRNewswire/ -- NewcelX Ltd. ("NewcelX") (Nasdaq: ...

TD Cowen 46th Annual Health Care Conference March 2, 2026 1:10 PM ESTCompany ParticipantsSteven Harr - President, CEO ...

It may be possible to treat type 1 diabetes simply by re-educating the immune system. Researchers at Stanford Medicine have ...

Q4 2025 earnings call: cash runway to Q2 2028, OpRegen site expansion, AlloSCOPE progress—read key takeaways now.

Proof-of-concept trial in a single patient shows that cells can survive transplantation without immunosuppression ...

Obviously caveats must be drawn from a mouse model such as this, but the results have supercharged the team's determination.